JPH2 and heart disorder: The latter polyadic JMC augmentation occurred despite ∼70% lower JPH2 protein levels in atrial compared with ventricular tissue indicating a large margin of atrial JMC plasticity raising the potential for therapeutic augmentation in heart disease (82).